Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Effect of posterior vitreous detachment on treat-and-extend versus monthly ranibizumab for neovascular age-related macular degeneration.

Waldstein SM, Coulibaly L, Riedl S, Sadeghipour A, Gerendas BS, Schmidt-Erfurth UM.

Br J Ophthalmol. 2019 Sep 28. pii: bjophthalmol-2019-314661. doi: 10.1136/bjophthalmol-2019-314661. [Epub ahead of print]

PMID:
31563866
2.

Exploiting Epistemic Uncertainty of Anatomy Segmentation for Anomaly Detection in Retinal OCT.

Seebock P, Orlando JI, Schlegl T, Waldstein SM, Bogunovic H, Klimscha S, Langs G, Schmidt-Erfurth U.

IEEE Trans Med Imaging. 2019 May 31. doi: 10.1109/TMI.2019.2919951. [Epub ahead of print]

PMID:
31170065
3.

MORPHOLOGICAL AND FUNCTIONAL CHARACTERISTICS AT THE ONSET OF EXUDATIVE CONVERSION IN AGE-RELATED MACULAR DEGENERATION.

Hu X, Waldstein SM, Klimscha S, Sadeghipour A, Bogunovic H, Gerendas BS, Osborne A, Schmidt-Erfurth U.

Retina. 2019 Mar 28. doi: 10.1097/IAE.0000000000002531. [Epub ahead of print]

PMID:
30932998
4.

RETOUCH: The Retinal OCT Fluid Detection and Segmentation Benchmark and Challenge.

Bogunovic H, Venhuizen F, Klimscha S, Apostolopoulos S, Bab-Hadiashar A, Bagci U, Beg MF, Bekalo L, Chen Q, Ciller C, Gopinath K, Gostar AK, Jeon K, Ji Z, Kang SH, Koozekanani DD, Lu D, Morley D, Parhi KK, Park HS, Rashno A, Sarunic M, Shaikh S, Sivaswamy J, Tennakoon R, Yadav S, De Zanet S, Waldstein SM, Gerendas BS, Klaver C, Sanchez CI, Schmidt-Erfurth U.

IEEE Trans Med Imaging. 2019 Aug;38(8):1858-1874. doi: 10.1109/TMI.2019.2901398. Epub 2019 Feb 26.

PMID:
30835214
5.

f-AnoGAN: Fast unsupervised anomaly detection with generative adversarial networks.

Schlegl T, Seeböck P, Waldstein SM, Langs G, Schmidt-Erfurth U.

Med Image Anal. 2019 May;54:30-44. doi: 10.1016/j.media.2019.01.010. Epub 2019 Jan 31.

PMID:
30831356
6.

Unsupervised Identification of Disease Marker Candidates in Retinal OCT Imaging Data.

Seebock P, Waldstein SM, Klimscha S, Bogunovic H, Schlegl T, Gerendas BS, Donner R, Schmidt-Erfurth U, Langs G.

IEEE Trans Med Imaging. 2019 Apr;38(4):1037-1047. doi: 10.1109/TMI.2018.2877080. Epub 2018 Oct 22.

PMID:
30346281
7.

Artificial intelligence in retina.

Schmidt-Erfurth U, Sadeghipour A, Gerendas BS, Waldstein SM, Bogunović H.

Prog Retin Eye Res. 2018 Nov;67:1-29. doi: 10.1016/j.preteyeres.2018.07.004. Epub 2018 Aug 1. Review.

8.

[Screening and management of retinal diseases using digital medicine].

Gerendas BS, Waldstein SM, Schmidt-Erfurth U.

Ophthalmologe. 2018 Sep;115(9):728-736. doi: 10.1007/s00347-018-0752-7. Review. German.

PMID:
29980857
9.

Prediction of Individual Disease Conversion in Early AMD Using Artificial Intelligence.

Schmidt-Erfurth U, Waldstein SM, Klimscha S, Sadeghipour A, Hu X, Gerendas BS, Osborne A, Bogunovic H.

Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3199-3208. doi: 10.1167/iovs.18-24106.

PMID:
29971444
10.

Neuroretinal atrophy following resolution of macular oedema in retinal vein occlusion.

Podkowinski D, Philip AM, Vogl WD, Gamper J, Bogunovic H, Gerendas BS, Haj Najeeb B, Waldstein SM, Schmidt-Erfurth U.

Br J Ophthalmol. 2019 Jan;103(1):36-42. doi: 10.1136/bjophthalmol-2017-311614. Epub 2018 Mar 6.

PMID:
29511062
11.

Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema: A Subanalysis of the RESTORE (Extension) Study.

Karst SG, Deak GG, Gerendas BS, Waldstein SM, Lammer J, Simader C, Guerin T, Schmidt-Erfurth UM.

JAMA Ophthalmol. 2018 Apr 1;136(4):315-321. doi: 10.1001/jamaophthalmol.2017.6135.

12.

Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study.

Larsen M, Waldstein SM, Priglinger S, Hykin P, Barnes E, Gekkieva M, Das Gupta A, Wenzel A, Monés J; CRYSTAL Study Group.

Ophthalmol Retina. 2018 Feb;2(2):134-142. doi: 10.1016/j.oret.2017.05.016. Epub 2017 Sep 9.

PMID:
31047340
13.

Machine Learning to Analyze the Prognostic Value of Current Imaging Biomarkers in Neovascular Age-Related Macular Degeneration.

Schmidt-Erfurth U, Bogunovic H, Sadeghipour A, Schlegl T, Langs G, Gerendas BS, Osborne A, Waldstein SM.

Ophthalmol Retina. 2018 Jan;2(1):24-30. doi: 10.1016/j.oret.2017.03.015. Epub 2017 May 31.

PMID:
31047298
14.

Fully Automated Detection and Quantification of Macular Fluid in OCT Using Deep Learning.

Schlegl T, Waldstein SM, Bogunovic H, Endstraßer F, Sadeghipour A, Philip AM, Podkowinski D, Gerendas BS, Langs G, Schmidt-Erfurth U.

Ophthalmology. 2018 Apr;125(4):549-558. doi: 10.1016/j.ophtha.2017.10.031. Epub 2017 Dec 8.

15.

Analyzing and Predicting Visual Acuity Outcomes of Anti-VEGF Therapy by a Longitudinal Mixed Effects Model of Imaging and Clinical Data.

Vogl WD, Waldstein SM, Gerendas BS, Schlegl T, Langs G, Schmidt-Erfurth U.

Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4173-4181. doi: 10.1167/iovs.17-21878.

PMID:
28837729
16.

Spatial Correspondence Between Intraretinal Fluid, Subretinal Fluid, and Pigment Epithelial Detachment in Neovascular Age-Related Macular Degeneration.

Klimscha S, Waldstein SM, Schlegl T, Bogunovic H, Sadeghipour A, Philip AM, Podkowinski D, Pablik E, Zhang L, Abramoff MD, Sonka M, Gerendas BS, Schmidt-Erfurth U.

Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4039-4048. doi: 10.1167/iovs.16-20201.

PMID:
28813577
17.

Sustained Benefits of Ranibizumab with or without Laser in Branch Retinal Vein Occlusion: 24-Month Results of the BRIGHTER Study.

Tadayoni R, Waldstein SM, Boscia F, Gerding H, Gekkieva M, Barnes E, Das Gupta A, Wenzel A, Pearce I; BRIGHTER Study Group.

Ophthalmology. 2017 Dec;124(12):1778-1787. doi: 10.1016/j.ophtha.2017.06.027. Epub 2017 Aug 12. Erratum in: Ophthalmology. 2018 Mar;125(3):463.

18.

Predictive imaging biomarkers relevant for functional and anatomical outcomes during ranibizumab therapy of diabetic macular oedema.

Gerendas BS, Prager S, Deak G, Simader C, Lammer J, Waldstein SM, Guerin T, Kundi M, Schmidt-Erfurth UM.

Br J Ophthalmol. 2018 Feb;102(2):195-203. doi: 10.1136/bjophthalmol-2017-310483. Epub 2017 Jul 19.

PMID:
28724636
19.

Joint retinal layer and fluid segmentation in OCT scans of eyes with severe macular edema using unsupervised representation and auto-context.

Montuoro A, Waldstein SM, Gerendas BS, Schmidt-Erfurth U, Bogunović H.

Biomed Opt Express. 2017 Feb 27;8(3):1874-1888. doi: 10.1364/BOE.8.001874. eCollection 2017 Mar 1.

20.

Prediction of Anti-VEGF Treatment Requirements in Neovascular AMD Using a Machine Learning Approach.

Bogunovic H, Waldstein SM, Schlegl T, Langs G, Sadeghipour A, Liu X, Gerendas BS, Osborne A, Schmidt-Erfurth U.

Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):3240-3248. doi: 10.1167/iovs.16-21053.

PMID:
28660277
21.

Machine Learning of the Progression of Intermediate Age-Related Macular Degeneration Based on OCT Imaging.

Bogunovic H, Montuoro A, Baratsits M, Karantonis MG, Waldstein SM, Schlanitz F, Schmidt-Erfurth U.

Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO141-BIO150. doi: 10.1167/iovs.17-21789.

PMID:
28658477
22.

Impact of B-Scan Averaging on Spectralis Optical Coherence Tomography Image Quality before and after Cataract Surgery.

Podkowinski D, Sharian Varnousfaderani E, Simader C, Bogunovic H, Philip AM, Gerendas BS, Schmidt-Erfurth U, Waldstein SM.

J Ophthalmol. 2017;2017:8148047. doi: 10.1155/2017/8148047. Epub 2017 May 23.

23.

Evaluating the impact of vitreomacular adhesion on anti-VEGF therapy for retinal vein occlusion using machine learning.

Waldstein SM, Montuoro A, Podkowinski D, Philip AM, Gerendas BS, Bogunovic H, Schmidt-Erfurth U.

Sci Rep. 2017 Jun 7;7(1):2928. doi: 10.1038/s41598-017-02971-y.

24.

Predicting Macular Edema Recurrence from Spatio-Temporal Signatures in Optical Coherence Tomography Images.

Vogl WD, Waldstein SM, Gerendas BS, Schmidt-Erfurth U, Langs G.

IEEE Trans Med Imaging. 2017 Sep;36(9):1773-1783. doi: 10.1109/TMI.2017.2700213. Epub 2017 May 2.

PMID:
28475051
25.

Computational image analysis for prognosis determination in DME.

Gerendas BS, Bogunovic H, Sadeghipour A, Schlegl T, Langs G, Waldstein SM, Schmidt-Erfurth U.

Vision Res. 2017 Oct;139:204-210. doi: 10.1016/j.visres.2017.03.008. Epub 2017 May 9.

26.

Supervised learning and dimension reduction techniques for quantification of retinal fluid in optical coherence tomography images.

Breger A, Ehler M, Bogunovic H, Waldstein SM, Philip AM, Schmidt-Erfurth U, Gerendas BS.

Eye (Lond). 2017 Aug;31(8):1212-1220. doi: 10.1038/eye.2017.61. Epub 2017 Apr 21.

27.

A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration.

Schmidt-Erfurth U, Klimscha S, Waldstein SM, Bogunović H.

Eye (Lond). 2017 Jan;31(1):26-44. doi: 10.1038/eye.2016.227. Epub 2016 Nov 25. Review.

28.

Automated Fovea Detection in Spectral Domain Optical Coherence Tomography Scans of Exudative Macular Disease.

Wu J, Waldstein SM, Montuoro A, Gerendas BS, Langs G, Schmidt-Erfurth U.

Int J Biomed Imaging. 2016;2016:7468953. doi: 10.1155/2016/7468953. Epub 2016 Aug 31.

29.

Multivendor Spectral-Domain Optical Coherence Tomography Dataset, Observer Annotation Performance Evaluation, and Standardized Evaluation Framework for Intraretinal Cystoid Fluid Segmentation.

Wu J, Philip AM, Podkowinski D, Gerendas BS, Langs G, Simader C, Waldstein SM, Schmidt-Erfurth UM.

J Ophthalmol. 2016;2016:3898750. doi: 10.1155/2016/3898750. Epub 2016 Aug 4.

30.

A novel benchmark model for intelligent annotation of spectral-domain optical coherence tomography scans using the example of cyst annotation.

Shahrian Varnousfaderani E, Wu J, Vogl WD, Philip AM, Montuoro A, Leitner R, Simader C, Waldstein SM, Gerendas BS, Schmidt-Erfurth U.

Comput Methods Programs Biomed. 2016 Jul;130:93-105. doi: 10.1016/j.cmpb.2016.03.012. Epub 2016 Mar 16.

PMID:
27208525
31.

Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials.

Waldstein SM, Simader C, Staurenghi G, Chong NV, Mitchell P, Jaffe GJ, Lu C, Katz TA, Schmidt-Erfurth U.

Ophthalmology. 2016 Jul;123(7):1521-9. doi: 10.1016/j.ophtha.2016.03.037. Epub 2016 May 4.

PMID:
27157149
32.

Individualized Stabilization Criteria-Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion: Six-Month Results of BRIGHTER.

Tadayoni R, Waldstein SM, Boscia F, Gerding H, Pearce I, Priglinger S, Wenzel A, Barnes E, Gekkieva M, Pilz S, Monés J; BRIGHTER study group.

Ophthalmology. 2016 Jun;123(6):1332-44. doi: 10.1016/j.ophtha.2016.02.030. Epub 2016 Mar 30.

33.

Individualized Ranibizumab Regimen Driven by Stabilization Criteria for Central Retinal Vein Occlusion: Twelve-Month Results of the CRYSTAL Study.

Larsen M, Waldstein SM, Boscia F, Gerding H, Monés J, Tadayoni R, Priglinger S, Wenzel A, Barnes E, Pilz S, Stubbings W, Pearce I; CRYSTAL Study Group.

Ophthalmology. 2016 May;123(5):1101-11. doi: 10.1016/j.ophtha.2016.01.011. Epub 2016 Feb 17.

34.

Choroidal thickness maps from spectral domain and swept source optical coherence tomography: algorithmic versus ground truth annotation.

Philip AM, Gerendas BS, Zhang L, Faatz H, Podkowinski D, Bogunovic H, Abramoff MD, Hagmann M, Leitner R, Simader C, Sonka M, Waldstein SM, Schmidt-Erfurth U.

Br J Ophthalmol. 2016 Oct;100(10):1372-6. doi: 10.1136/bjophthalmol-2015-307985. Epub 2016 Jan 14.

35.

Correlation of 3-Dimensionally Quantified Intraretinal and Subretinal Fluid With Visual Acuity in Neovascular Age-Related Macular Degeneration.

Waldstein SM, Philip AM, Leitner R, Simader C, Langs G, Gerendas BS, Schmidt-Erfurth U.

JAMA Ophthalmol. 2016 Feb;134(2):182-90. doi: 10.1001/jamaophthalmol.2015.4948.

PMID:
26661463
36.

Choroidal Line Scan Measurements in Swept-Source Optical Coherence Tomography as Surrogates for Volumetric Thickness Assessment.

Gerendas BS, Hecht A, Kundi M, Waldstein SM, Deak G, Simader C, Montuoro A, Schmidt-Erfurth U, Funk M.

Am J Ophthalmol. 2016 Feb;162:150-158.e1. doi: 10.1016/j.ajo.2015.10.020. Epub 2015 Nov 3.

PMID:
26546563
37.

Predictive Value of Retinal Morphology for Visual Acuity Outcomes of Different Ranibizumab Treatment Regimens for Neovascular AMD.

Waldstein SM, Wright J, Warburton J, Margaron P, Simader C, Schmidt-Erfurth U.

Ophthalmology. 2016 Jan;123(1):60-9. doi: 10.1016/j.ophtha.2015.09.013. Epub 2015 Oct 17.

PMID:
26481821
38.

A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration.

Schmidt-Erfurth U, Waldstein SM.

Prog Retin Eye Res. 2016 Jan;50:1-24. doi: 10.1016/j.preteyeres.2015.07.007. Epub 2015 Aug 22. Review.

PMID:
26307399
39.

Predicting Semantic Descriptions from Medical Images with Convolutional Neural Networks.

Schlegl T, Waldstein SM, Vogl WD, Schmidt-Erfurth U, Langs G.

Inf Process Med Imaging. 2015;24:437-48.

PMID:
26221693
40.

Spatio-Temporal Signatures to Predict Retinal Disease Recurrence.

Vogl WD, Waldstein SM, Gerendas BS, Simader C, Glodan AM, Podkowinski D, Schmidt-Erfurth U, Langs G.

Inf Process Med Imaging. 2015;24:152-63.

PMID:
26221672
41.

Comparison of penetration depth in choroidal imaging using swept source vs spectral domain optical coherence tomography.

Waldstein SM, Faatz H, Szimacsek M, Glodan AM, Podkowinski D, Montuoro A, Simader C, Gerendas BS, Schmidt-Erfurth U.

Eye (Lond). 2015 Mar;29(3):409-15. doi: 10.1038/eye.2014.319. Epub 2015 Jan 16.

42.

Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.

Schmidt-Erfurth U, Waldstein SM, Deak GG, Kundi M, Simader C.

Ophthalmology. 2015 Apr;122(4):822-32. doi: 10.1016/j.ophtha.2014.11.017. Epub 2015 Jan 9.

PMID:
25578255
43.

Quantitative comparison of macular segmentation performance using identical retinal regions across multiple spectral-domain optical coherence tomography instruments.

Waldstein SM, Gerendas BS, Montuoro A, Simader C, Schmidt-Erfurth U.

Br J Ophthalmol. 2015 Jun;99(6):794-800. doi: 10.1136/bjophthalmol-2014-305573. Epub 2015 Jan 6.

PMID:
25563763
44.

Three-dimensional automated choroidal volume assessment on standard spectral-domain optical coherence tomography and correlation with the level of diabetic macular edema.

Gerendas BS, Waldstein SM, Simader C, Deak G, Hajnajeeb B, Zhang L, Bogunovic H, Abramoff MD, Kundi M, Sonka M, Schmidt-Erfurth U.

Am J Ophthalmol. 2014 Nov;158(5):1039-48. doi: 10.1016/j.ajo.2014.08.001. Epub 2014 Aug 12.

45.

Impact of vitreomacular adhesion on ranibizumab mono- and combination therapy for neovascular age-related macular degeneration.

Waldstein SM, Ritter M, Simader C, Mayr-Sponer U, Kundi M, Schmidt-Erfurth U.

Am J Ophthalmol. 2014 Aug;158(2):328-336.e1. doi: 10.1016/j.ajo.2014.04.028. Epub 2014 May 2.

PMID:
24794282
46.

Influence of the vitreomacular interface on outcomes of ranibizumab therapy in neovascular age-related macular degeneration.

Mayr-Sponer U, Waldstein SM, Kundi M, Ritter M, Golbaz I, Heiling U, Papp A, Simader C, Schmidt-Erfurth U.

Ophthalmology. 2013 Dec;120(12):2620-2629. doi: 10.1016/j.ophtha.2013.05.032. Epub 2013 Jul 16.

PMID:
23870300
47.

Two-wavelength fundus autofluorescence and macular pigment optical density imaging in diabetic macular oedema.

Waldstein SM, Hickey D, Mahmud I, Kiire CA, Charbel Issa P, Chong NV.

Eye (Lond). 2012 Aug;26(8):1078-85. doi: 10.1038/eye.2012.100. Epub 2012 Jun 15.

48.

Influence of vitreomacular adhesion on the development of exudative age-related macular degeneration: 4-year results of a longitudinal study.

Waldstein SM, Sponer U, Simader C, Sacu S, Schmidt-Erfurth U.

Retina. 2012 Mar;32(3):424-33. doi: 10.1097/IAE.0b013e3182278b80.

PMID:
22105497

Supplemental Content

Loading ...
Support Center